Iovance Biotherapeutics (IOVA) has had the highest return since June 30, 2026 by a US stock with a market cap of $5B+, returning 235.9%.
| ASSET | % RETURN |
|---|---|
Iovance Biotherapeutics (IOVA) | 235.93% |
Moderna (MRNA) | 224.05% |
Atlassian (TEAM) | 164.11% |
CVR Energy (CVI) | 117.65% |
NIQ Global Intelligence (NIQ) | 116.75% |
Kodiak Sciences (KOD) | 113% |
GRAIL, LLC (GRAL) | 103.35% |
10X Genomics (TXG) | 96.77% |
Ringcentral (RNG) | 96.64% |
Everpure (P) | 95.78% |
PBF Energy (PBF) | 91.93% |
Paycom Software (PAYC) | 91.38% |
Netskope, Inc Class A Common Stock (NTSK) | 90.31% |
Xp (XP) | 88.79% |
Marathon Petroleum (MPC) | 86.57% |
Gitlab (GTLB) | 81.06% |
HF Sinclair (DINO) | 80.3% |
Accenture (ACN) | 77.91% |
Palantir Technologies (PLTR) | 74.83% |
Valero Energy (VLO) | 72.87% |
Bending Spoons SpA (BSP) | 72.45% |
Frontline (FRO) | 72.04% |
PTC (PTC) | 71.79% |
Phillips 66 (PSX) | 70.7% |
Veeva Systems Inc Class A (VEEV) | 70.55% |